| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/05/2004 | CA2264243C Glp-1 derivatives |
| 10/05/2004 | CA2128833C P53as protein and antibody therefor |
| 09/30/2004 | WO2004083865A2 Materials and methods for modulating cell motility |
| 09/30/2004 | WO2004083807A2 Methods of evaluating glycomolecules for enhanced activities |
| 09/30/2004 | WO2004083448A2 Molecular differences between species of the m.tuberculosis complex |
| 09/30/2004 | WO2004083447A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 09/30/2004 | WO2004083445A2 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof |
| 09/30/2004 | WO2004083438A1 A new peptide against enterococcus faecalis and the method of producing it |
| 09/30/2004 | WO2004083437A1 A new peptide against streptococcus pneumoniae and the method of producing it |
| 09/30/2004 | WO2004083436A2 Novel bt toxin receptors and methods of use |
| 09/30/2004 | WO2004083435A1 Nab proteins and their use in diagnostic and therapeutic applications in heart disease |
| 09/30/2004 | WO2004083422A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies |
| 09/30/2004 | WO2004083418A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby |
| 09/30/2004 | WO2004083417A1 The transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same |
| 09/30/2004 | WO2004083404A2 Gene therapy vectors having reduced immunogenicity based on cd8 alpha-chain |
| 09/30/2004 | WO2004083398A2 Therapeutic uses of hmgn1 and hmgn2 |
| 09/30/2004 | WO2004083397A2 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 09/30/2004 | WO2004083395A2 Transporters and ion channels |
| 09/30/2004 | WO2004083394A2 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
| 09/30/2004 | WO2004083393A2 Enhanced protein thermostability and temperature resistance |
| 09/30/2004 | WO2004083390A2 Virulent systemic feline calicivirus |
| 09/30/2004 | WO2004083389A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 09/30/2004 | WO2004083388A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
| 09/30/2004 | WO2004083385A2 Quorum sensing signaling in bacteria |
| 09/30/2004 | WO2004083383A2 Globin variant gene methods and compositions |
| 09/30/2004 | WO2004083381A2 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 09/30/2004 | WO2004083372A2 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses |
| 09/30/2004 | WO2004083257A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 09/30/2004 | WO2004083251A2 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| 09/30/2004 | WO2004083245A2 Agent comprise an albumin-like first polypeptide bound to a second polypeptide |
| 09/30/2004 | WO2004083244A2 Specific inhibition of allograft rejection |
| 09/30/2004 | WO2004083243A1 Amylin aggregation inhibitors and use thereof. |
| 09/30/2004 | WO2004083242A1 Human granulocyte-colony stimulating factor conjugate having enhanced stability in blood and process for the preparation thereof |
| 09/30/2004 | WO2004083241A2 Btc-interacting proteins and use thereof |
| 09/30/2004 | WO2004083239A1 Determining drug resistance |
| 09/30/2004 | WO2004083234A2 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 09/30/2004 | WO2004083154A1 Improved extraction process |
| 09/30/2004 | WO2004082720A1 Drug for treating hemophilia and method of treating hemophilia using the same |
| 09/30/2004 | WO2004082710A1 Treatment of allergic diseases using a modulator of the notch signaling pathway |
| 09/30/2004 | WO2004082704A1 Method of treating inflammtory disease associated with bone destruction |
| 09/30/2004 | WO2004082690A1 Regulation of cell surface proteins |
| 09/30/2004 | WO2004082640A2 Human serum albumin conjugates with therapeutic compounds |
| 09/30/2004 | WO2004082608A2 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | WO2004082598A2 Relaxin3-gpcr135 complexes and their production and use |
| 09/30/2004 | WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 09/30/2004 | WO2004082567A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 09/30/2004 | WO2004082455A2 Method for detecting alzheimer’s disease and corresponding peptides and detection reagents |
| 09/30/2004 | WO2004082374A1 Model for muscular dystrophy and cardiomyopathy |
| 09/30/2004 | WO2004082370A2 Cardiac-preferred genetic alteration of transgenic rabbits |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004074313A8 Methods for prediction of amyloid fibril formation and identification of peptides useful as therapeutic and diagnostic agents |
| 09/30/2004 | WO2004063332A9 Cancer related genes |
| 09/30/2004 | WO2004063226A3 Novel fibrillin-like polypeptides |
| 09/30/2004 | WO2004062478A9 Isolation and characterization of eca1, a gene overexpressed in endometrioid carcinomas of ovary and endometrium |
| 09/30/2004 | WO2004060408A8 p53 TREATMENT OF PAPILLOMAVIRUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS |
| 09/30/2004 | WO2004058807A3 Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
| 09/30/2004 | WO2004058146A3 Novel compositions and methods in cancer |
| 09/30/2004 | WO2004056863A8 Splice variant of human placental growth hormone |
| 09/30/2004 | WO2004056861A3 Glycoisoforms of adiponectin and uses thereof |
| 09/30/2004 | WO2004056850A3 Mutant proteins showing increased secretion |
| 09/30/2004 | WO2004052917A9 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 09/30/2004 | WO2004050843A3 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
| 09/30/2004 | WO2004046355A3 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 09/30/2004 | WO2004045544A3 Autocrine growth factor receptor antibodies and methods |
| 09/30/2004 | WO2004044004A3 T cell receptor display |
| 09/30/2004 | WO2004038377A3 Method for diagnosing renal diseases or predispositions |
| 09/30/2004 | WO2004035783A9 Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway |
| 09/30/2004 | WO2004035739A3 Treating androgen decline in aging male (adam)-associated conditions with sarms |
| 09/30/2004 | WO2004035618A3 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 09/30/2004 | WO2004035610A3 Refolding of ionic channel proteins |
| 09/30/2004 | WO2004031411A3 Genes and polypeptides relating to human pancreatic cancers |
| 09/30/2004 | WO2004022059A3 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 09/30/2004 | WO2004020467A3 Novel mucin binding polypeptides derived from lactobacillus johnsonii |
| 09/30/2004 | WO2004007663A3 Gene expression using metal ion dependent repressor/operator tandems |
| 09/30/2004 | WO2003106972A3 Multiple domain tdf-related compounds and analogs thereof |
| 09/30/2004 | WO2003099860A3 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition |
| 09/30/2004 | WO2003082200A3 Potent oncolytic herpes simplex virus for cancer therapy |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003073097A3 Methods for isolating ligands e.g. t cell epitopes |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | WO2003046152A3 Molecules for disease detection and treatment |
| 09/30/2004 | WO2003039491A3 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/30/2004 | WO2003014323A3 Human smooth muscle myosin heavy chain |
| 09/30/2004 | US20040194165 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants |
| 09/30/2004 | US20040194163 GTP binding stress-related proteins and methods of use in plants |
| 09/30/2004 | US20040194160 Expression vector comprising nucleotide sequences coding glucocorticoid-induced leucine-zipper family related protein (GILR) and tissue specific regulatory regions for transformation and generation of animal models to identify glucocorticoid hormones regulated genes associated with apoptosis control |
| 09/30/2004 | US20040194158 Model for neurodegenerative disorders |
| 09/30/2004 | US20040194155 Comprises hepatitis b viral nucleotide sequences coding mutant reverse transcriptase for use in developing antibodies to prevent or treat hepatitis viral infection; immunotherapy; |
| 09/30/2004 | US20040193921 Systems and methods for authenticating a user to a web server |
| 09/30/2004 | US20040192903 Comprises chromosomal regoin which codes pathogenicity islands (PAIs) for use in developing antibodies to detect and prevent bacterial infection; bactericides |
| 09/30/2004 | US20040192899 B-7 domain-specific antibodies |
| 09/30/2004 | US20040192896 Isolating wheat protein from flour; mixing milled flour with water and digesting enzyme, maturing mixture in tank, forming dough, rinse and feed into comminuting machine, recover smaller pieces and dry |
| 09/30/2004 | US20040192895 Extracting plant protein from defatted jojoba meal comprising forming aqueous dispersion with defatted jojoba meal, filtering, drying and recovering plant protein permeate; cosmetics nutraceutical |
| 09/30/2004 | US20040192892 Isolated mammalian membrane protein genes; related reagents |
| 09/30/2004 | US20040192891 Mammalian cytokines; related reagents and methods |
| 09/30/2004 | US20040192890 Comprises adenosine triphosphatase peptides for identifying modulators for treatment of cell proliferative, inflammatory and nervous system disorders |
| 09/30/2004 | US20040192889 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 09/30/2004 | US20040192887 Preparing enhanced diagnostic assay for detection of spongiform encephalopalies using hydrogen ion concentration sensitive fusion protein comprising prion octapeptide sequences |